Stay updated on DARA/ATRA Combo in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.

Latest updates to the DARA/ATRA Combo in Myeloma: Clinical Trial page
- Check5 days agoChange DetectedThe related topics section no longer lists links for 'Multiple myeloma' and MedlinePlus Genetics, removing external resource pointers from the study page.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page’s revision label updates from v3.6.2 to v3.6.3, indicating a minor maintenance update to the ClinicalTrials.gov page template. There are no changes to the study content, eligibility criteria, or reported results visible on the page.SummaryDifference0.1%

- Check19 days agoChange DetectedRelated topics now include Multiple myeloma and MedlinePlus Genetics. The site revision label updates from v3.6.0 to v3.6.2 in the footer.SummaryDifference0.2%

- Check26 days agoChange DetectedThe page's content loses the explicit disease label 'Multiple myeloma' and associated related topic links (including MedlinePlus Genetics), removing explicit disease context and related resource references from the study details.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now indicates that enrollment is closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), while the Intervention / Treatment heading formatting has been updated to Intervention/Treatment.SummaryDifference0.6%

- Check41 days agoChange DetectedThe page shows a revision label update from v3.5.4 to v3.5.5, signaling a new version of the page. This update does not appear to alter the study content or main functionality.SummaryDifference0.1%

Stay in the know with updates to DARA/ATRA Combo in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.